Form 8-K - Current report:
SEC Accession No. 0001104659-25-027233
Filing Date
2025-03-24
Accepted
2025-03-24 16:30:17
Documents
13
Period of Report
2025-03-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm259994d1_8k.htm   iXBRL 8-K 246969
  Complete submission text file 0001104659-25-027233.txt   444277

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cara-20250324.xsd EX-101.SCH 3039
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20250324_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20250324_pre.xml EX-101.PRE 22375
15 EXTRACTED XBRL INSTANCE DOCUMENT tm259994d1_8k_htm.xml XML 3683
Mailing Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901
Business Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 25764526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)